logo
episode-header-image
Jul 2023
20m 4s

Anglerfish, Gila Monsters, and the Origi...

The Motley Fool
About this episode
Weight loss drug sales are estimated to hit $44 billion by 2030. Many of these treatments can thank previously obscure research on a carnivorous deep sea fish for their development. Rolfe Winkler is a reporter for the Wall Street Journal covering digital health. Ricky Mulvey caught up with Winkler to discuss: - The origins and science behind weight loss dr ... Show More
Up next
Yesterday
IT Consulting is Not Having a Good Time
Data centers might have a climate problem. With more than 80% of data centers worldwide in regions at high risk of drought, flooding, or wildfires. The implication of these trillions in investment being at elevated risk to weather related disasters could have some major downstrea ... Show More
21m 24s
Jun 17
Snap’s Specs Gamble
The smartphone could be a thing of the past if Snap has its way an Specs take over the market. But at $2,195 it could be a tall task selling these to consumers, even if they were stylish. Plus, we talk about Rivian’s layoffs and Eli Lilly’s latest acquisition. Travis Hoium, Lou W ... Show More
18m 45s
Jun 16
Buying Your Own Sports Team (with Stocks)
Pretty much every sports fan dreams of owning their favorite team. Between the bragging rights and the courtside seats, who wouldn’t want to be? While you may not be able to be a partial owner of your favorite team, there are a few opportunities to own a part of team in almost ev ... Show More
22m 15s
Recommended Episodes
Jun 2024
The weight-loss drug revolution
Diabetes and obesity drugs like Ozempic, Wegovy and Mounjaro have become famous for helping users shed big amounts of weight. It's a market that could soon be worth more than $100 billion. Two companies dominate this space, Novo Nordisk which makes Ozempic and Eli Lilly, maker of ... Show More
17m 28s
Feb 2024
The Big Business Behind Weight Loss Drugs
It’s become a multibillion-dollar business: weight loss drugs. Demand is high, as is the cost. How did medications like Ozempic, Wegovy, Mounjaro and Zepbound become so popular and so profitable? And what kind of impact might they have on the future of food and healthcare? Dr. Sa ... Show More
33m 54s
Mar 2017
113. Susan Peirce Thompson went from being addicted to drugs and alcohol to turning her life around, and building a multi-million dollar weight loss business.
Susan Peirce Thompson is an entrepreneur, brain and cognitive scientist, and food psychologist. She's a Ph.D, and author of the new book Bright Line Eating: The Science of Living Happy, Thin, & Free. She built her business to over $6MM in revenue (with a 300k+ list) in under a ye ... Show More
30m 9s
Mar 2024
The Scientific Journey Behind Ozempic (with Lotte Bjerre Knudsen, Novo Nordisk's Chief Scientific Advisor)
On our Novo Nordisk episode, we covered the business of Ozempic, the GLP-1 taking the world by storm. On this episode, we dive into the science of the molecule semaglutide (and its predecessor liraglutide) with the world expert on the topic, Lotte Bjerre Knudsen. Lotte is Novo No ... Show More
1 h
Nov 2023
#705: Dr. Willoughby Britton — The Hidden Risks of Meditation, Overlaps with Psychedelic Risks, Harm Reduction Strategies, How to Choose a Retreat, Near-Death Experiences, and More
Brought to you by Momentous high-quality supplements, Nordic Naturals Ultimate Omega fish oil, and Eight Sleep’s Pod Cover sleeping solution for dynamic cooling and heating.Willoughby Britton, PhD is a clinical psychologist, an associate professor of psychiatry and human behavior ... Show More
2h 3m
Mar 2023
NHS weight-loss drug
James Gallagher asks whether a weight-loss drug on the NHS heralds a new era in tackling obesity? He meets Jan who lost nearly 4 stone after being part of a trial taking a weekly injection of Semaglutide for 15 months alongside advice on meals and exercise. However, when people s ... Show More
27m 57s
Jan 2023
Terence Flynn: The Next Blockbuster for Pharma?
tail spinning
3m 12s
Oct 2023
Confronting An Obesity Doctor About Ozempic & Weight Loss | Dr. Rocio Salas-Whalen
<p>Watch the full video interview here: https://go.doctormikemedia.com/youtube/RSWOzempicDr. Rocio Salas-Whalen is a double board-certified physician with broad experience across all facets of endocrinology, with a particular emphasis on obesity, diabetes and thyroid disorders. S ... Show More
52m 37s